Can Postmarketing Surveillance Help to Effect Optimal Drug Therapy?

Brian Strom, Kenneth L. Melmon

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Abstract

Postmarketing drug surveillance (PMS) assesses the epidemiology of drug use and monitors beneficial or harmful effects of drugs following marketing. If used systematically, PMS can substantially improve drug therapy in the United States. This can be accomplished by generating information on drug use and effects otherwise unavailable, by enabling a more efficient drug approval process, and by educating drug prescribers. However, to be successful, any PMS system will need a good deal of input from such prescribers.

Original languageEnglish (US)
Pages (from-to)2420-2423
Number of pages4
JournalJAMA: The Journal of the American Medical Association
Volume242
Issue number22
DOIs
StatePublished - Nov 30 1979
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Fingerprint Dive into the research topics of 'Can Postmarketing Surveillance Help to Effect Optimal Drug Therapy?'. Together they form a unique fingerprint.

Cite this